Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Foundation Medicine Inc (FMI)

NASDAQ
Currency in USD
Disclaimer
137.00
0.00(0.00%)
Real-time Data
FMI Scorecard
Fair Value
Unlock Value
Day's Range
136.75137.00
52 wk Range
0.00137.00
Prev. Close
136.8
Open
136.8
Day's Range
136.75-137
52 wk Range
0-0
Volume
0
Average Vol. (3m)
306,168
1-Year Change
0%
Shares Outstanding
37,137,339
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about FMI?
Vote to see community's results!
or

Foundation Medicine Inc Company Profile

Foundation Medicine, Inc. develops genomic profiling tests that guide treatment strategies for cancer patients. The company provides FoundationOne CDx, a tissue-based companion diagnostic test for solid tumors; FoundationOne Liquid CDx, a blood-based companion diagnostic test for solid tumors; and a laboratory developed test for hematologic malignancies, sarcomas, or solid tumors. It also offers biopharma partner services. Foundation Medicine, Inc. was formerly known as Foundation Genomics, Inc. and changed its name to Foundation Medicine, Inc. in February 2010. The company was incorporated in 2009 and is based in Cambridge, Massachusetts with additional locations in Morrisville, North Carolina; Penzberg, Germany; and San Diego, California. As of January 31, 2022, Foundation Medicine, Inc. operates as a subsidiary of Roche Holdings, Inc.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.